Corporate Snapshot

Millennium Biotechnologies Group, Inc. ("Millennium" or "the Company") engages in the research, development, and marketing of specialized nutritional supplements as an adjunct to medical treatments for select medical conditions, as well as for individuals seeking improved recovery and advanced performance. The Company's marketed products are targeted toward immuno-compromised individuals undergoing medical treatment for diseases, such as cancer, as well as individuals living with Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) and for wound healing and post-surgical healing, among other conditions. Millennium's three proprietary, marketed products, which form the Company's Resurgex® Continuum of Care, include Resurgex Select®, Resurgex®, and Resurgex Plus®. Resurgex Select® is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex® and Resurgex Plus® are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium is also developing a Resurgex® Fusion sports nutrition formula, clinically proven to address the nutritional concerns of both professional and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. The Company expects to have Resurgex® Fusion on the market by late 2007, with potential marketing agreements with the National Collegiate Athletic Association (NCAA) and other pro-athletic organizations thereafter. Millennium is headquartered in Basking Ridge, New Jersey, and trades on the Over-the-Counter (OTC) market under the symbol "MBTG.OB."

* The Corporate Snapshot was last updated on June 12, 2007.

Latest Research

Executive
Informational
Overview

2007-06-12

Click to View

Stock Information (NRTI-OTC)